Naar content
Naar content

Beoordeling van stoffen - CoRAP

Last updated 17 februari 2020. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1
-
-
2020
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Not started
Details
-
37486-69-4
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
-
-
2018
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
show/hide
Tangled Multi-Walled Carbon Nanotubes EC / List no: 701-160-0 | CAS no: -
-
-
2019
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Wide dispersive use
Ongoing
Details
EC No. 415-490-5 and 604-250-7
-
-
2016
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Not started
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Conclusion under preparation
Details
200-467-2
60-29-7
2020
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
200-657-5
67-51-6
2020
Spain
Reprotoxic
High RCR
Not started
Details
200-659-6
67-56-1
2012
Poland
Suspected CMR
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
200-751-6
71-36-3
2017
Hungary
Suspected Reprotoxic
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-752-1
71-41-0
2016
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Concluded
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Ongoing
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Follow-up
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
200-889-7
75-65-0
2013
United Kingdom
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-159-0
78-93-3
2018
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Information requested
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Follow-up
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
Bisphenol A; BPA
201-245-8
80-05-7
2012
Germany
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
201-248-4
80-08-0
2016
Germany
Potential endocrine disruptor
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
201-279-3
80-43-3
2015
Norway
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
201-280-9
80-46-6
2014
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Ongoing
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Ongoing
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
201-344-6
81-33-4
2021
Belgium
Suspected PBT/vPvB
Not started
Details
DCHP
201-545-9
84-61-7
2017
Sweden
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Information requested
Details
201-550-6
84-66-2
2014
Germany
CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
201-983-0
90-30-2
2012
Germany
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
202-049-5
91-20-3
2016
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Concluded
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Conclusion under preparation
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Information requested
Details
202-394-1
95-14-7
2016
Germany
Potential endocrine disruptor
Exposure of environment
Information requested
Details
202-422-2
95-47-6
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
202-425-9
95-50-1
2013
Hungary
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
202-597-5
97-63-2
2014
Italy
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-626-1
98-00-0
2013
Poland
CMR
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-627-7
98-01-1
2021
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Ongoing
Details
202-773-1
99-62-7
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
202-826-9
100-18-5
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
202-859-9
100-51-6
2016
Germany
Suspected Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Follow-up
Details
202-860-4
100-52-7
2020
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
202-870-9
100-61-8
2021
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Not started
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-924-1
101-20-2
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Wide dispersive use
Ongoing
Details
202-966-0
101-68-8
2013
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Ongoing
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
203-090-1
103-23-1
2020
Finland
Suspected CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
203-234-3
104-76-7
2014
Poland
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
203-308-5
105-55-5
2019
Poland
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
203-312-7
105-59-9
2013
United Kingdom
Suspected CMR
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
203-376-6
106-23-0
2015
Sweden
Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-396-5
106-42-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
203-398-6
106-44-5
2015
United Kingdom
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
203-497-4
107-51-7
2015
Norway
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Follow-up
Details
203-545-4
108-05-4
2019
Latvia
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
203-576-3
108-38-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details
203-631-1
108-94-1
2016
Poland
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-686-1
109-60-4
2021
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-733-6
110-05-4
2016
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-777-6
110-54-3
2012
Germany
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details

Export search results to:

Categories Display

Getagd als:

(klik op de tag om te zoeken naar relevante inhoud)


Route: .live2